During the past decade, National Cheng Kung University Hospital / Internal Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Cheng Kung University Hospital / Internal Medicine" #1 sponsor was "Daiichi Sankyo, Inc." with 1 trials, followed by "National Cheng-Kung University Hospital" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Pharmaxis" with 1 trials sponsored and "Ping-Yen Liu" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cheng Kung University Hospital / Internal Medicine" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Cheng Kung University Hospital / Internal Medicine" are "Acute Coronary Syndrome" (1 trials), "Adult T Cell Leukemia/Lymphoma" (1 trials), "Breast Neoplasms" (1 trials), "Cardiovascular Diseases" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "National Cheng Kung University Hospital / Internal Medicine" in a lesser frequency.

Most popular intervention types in "National Cheng Kung University Hospital / Internal Medicine" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASCVD risk score" (1 trials), "Clopidogrel first" (1 trials), "Letrozole" (1 trials), "PXS-5505" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Cheng Kung University Hospital / Internal Medicine" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Cheng Kung University Hospital / Internal Medicine". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Cheng Kung University Hospital / Internal Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cheng Kung University Hospital / Internal Medicine, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".